Total Payments
$17,831
2024 Payments
$2,431
Companies
48
Transactions
1,203
Medicare Patients
3,559
Medicare Billing
$386,436
Payment Breakdown by Category
Food & Beverage$17,784 (99.7%)
Education$46.31 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,784 | 1,197 | 99.7% |
| Education | $46.31 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,639 | 273 | $0 (2024) |
| Lilly USA, LLC | $2,053 | 172 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,388 | 102 | $0 (2024) |
| Insulet Corporation | $1,357 | 69 | $0 (2024) |
| Amgen Inc. | $1,306 | 98 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,037 | 73 | $0 (2024) |
| Abbott Laboratories | $859.03 | 47 | $0 (2024) |
| ABBVIE INC. | $794.58 | 45 | $0 (2024) |
| Mannkind Corporation | $590.51 | 33 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $486.67 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,431 | 141 | Lilly USA, LLC ($439.92) |
| 2023 | $2,484 | 149 | Lilly USA, LLC ($461.49) |
| 2022 | $2,267 | 143 | Novo Nordisk Inc ($438.92) |
| 2021 | $1,654 | 105 | Novo Nordisk Inc ($536.92) |
| 2020 | $906.31 | 62 | Novo Nordisk Inc ($351.81) |
| 2019 | $2,603 | 184 | Novo Nordisk Inc ($548.60) |
| 2018 | $2,557 | 198 | Novo Nordisk Inc ($568.88) |
| 2017 | $2,927 | 221 | Novo Nordisk Inc ($651.99) |
All Payment Transactions
1,203 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Genetic Disease | ||||||
| 12/17/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $28.65 | General |
| 12/16/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/03/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Automated insulin delivery system | ||||||
| 12/02/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.15 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/22/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Insulin Pump | ||||||
| 11/12/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $28.10 | General |
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 11/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Endocrinology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 905 | 1,290 | $314,625 | $71,277 |
| 2022 | 7 | 766 | 1,212 | $318,643 | $70,061 |
| 2021 | 7 | 789 | 1,288 | $284,096 | $78,904 |
| 2020 | 15 | 1,099 | 6,358 | $716,727 | $166,195 |
Total Patients
3,559
Total Services
10,148
Medicare Billing
$386,436
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 500 | 830 | $233,076 | $53,042 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 175 | $30,766 | $7,975 | 25.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $15,210 | $4,825 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $8,373 | $1,710 | 20.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 36 | $9,756 | $1,312 | 13.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 138 | 138 | $10,814 | $1,257 | 11.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 30 | 51 | $6,630 | $1,156 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 424 | 807 | $240,162 | $52,794 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 164 | $33,155 | $7,467 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $11,132 | $3,722 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $15,648 | $3,306 | 21.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 25 | 49 | $6,370 | $1,182 | 18.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 113 | 113 | $8,924 | $1,094 | 12.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 12 | $3,252 | $495.61 | 15.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 436 | 864 | $207,072 | $59,093 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $17,732 | $6,797 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 147 | $22,917 | $6,595 | 28.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $11,760 | $2,917 | 24.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 25 | 59 | $7,670 | $1,459 | 19.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 34 | $9,214 | $1,078 | 11.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 100 | 100 | $7,731 | $964.00 | 12.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 56 | 4,680 | $227,958 | $72,461 | 31.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 432 | 811 | $277,763 | $57,678 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 137 | $36,047 | $6,469 | 17.9% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 55 | 141 | $27,789 | $5,340 | 19.2% |
About Dr. Gary Bakst, M.D
Dr. Gary Bakst, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275530537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Bakst, M.D has received a total of $17,831 in payments from pharmaceutical and medical device companies, with $2,431 received in 2024. These payments were reported across 1,203 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($17,784).
As a Medicare-enrolled provider, Bakst has provided services to 3,559 Medicare beneficiaries, totaling 10,148 services with total Medicare billing of $386,436. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Albany, NY
- Active Since 07/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1275530537
Products in Payments
- Ozempic (Drug) $1,642
- Omnipod (Device) $1,357
- FARXIGA (Drug) $1,263
- JARDIANCE (Drug) $799.66
- Victoza (Drug) $609.50
- EVENITY (Biological) $595.16
- AFREZZA (Drug) $590.51
- Korlym (Drug) $486.60
- Repatha (Biological) $473.95
- FREESTYLE LIBRE 3 (Device) $470.05
- MOUNJARO (Drug) $448.92
- INVOKANA (Drug) $434.88
- Saxenda (Drug) $430.44
- SYNTHROID (Drug) $373.64
- HUMULIN (Drug) $365.47
- SOLIQUA (Drug) $350.82
- Rybelsus (Drug) $329.95
- TRULICITY (Drug) $314.56
- SOMAVERT (Drug) $297.35
- Synthroid (Drug) $247.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Albany
Dr. Robert Busch, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4.1M
Endocrinology, Diabetes & Metabolism $4.1M
Dr. Gregg Gerety, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $665,599
Endocrinology, Diabetes & Metabolism $665,599
Dr. Jay Watsky, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $83,103
Endocrinology, Diabetes & Metabolism $83,103
Dr. Mark Fruiterman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,168
Endocrinology, Diabetes & Metabolism $37,168
Dr. Michael Walker, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,934
Endocrinology, Diabetes & Metabolism $17,934
Dr. Samer Eldeiry, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $9,611
Endocrinology, Diabetes & Metabolism $9,611